| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 18.56M | $1.28B | - | |
| 10% | 14.59M | $1.01B | - | |
| CEO | 4.40M | $303.14M | - | |
| Dir | 916.7K | $63.18M | - | |
| Dir | 766.6K | $52.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2020 | Homcy Charles J | Chairman Of Pharmaceuticals | Sale+OE | 10,000 | $38.00 | $380,000.00 | -0.8% | |
| Sep 29, 2020 | Homcy Charles J | Chairman Of Pharmaceuticals | Sell | 99,257 | $36.95 | $3,667,954.96 | -2.6% | |
| Sep 18, 2020 | Turtle Cameron | See Remarks | Sale+OE | 2,500 | $42.01 | $105,024.25 | -16.6% | |
| Sep 18, 2020 | Henderson Michael Thomas58 | Chief Business Officer | Sale+OE | 10,000 | $40.00 | $400,000.00 | -3.6% | |
| Sep 16, 2020 | Scheller Richard H90 | See Remarks | Sell | 25,000 | $37.50 | $937,500.00 | -15.3% | |
| Sep 15, 2020 | Turtle Cameron | See Remarks | Sale+OE | 2,500 | $37.06 | $92,651.75 | -16.6% | |
| Sep 11, 2020 | Turtle Cameron | See Remarks | Sale+OE | 2,000 | $35.02 | $70,047.00 | -13.7% | |
| Sep 1, 2020 | Henderson Michael Thomas58 | Chief Business Officer | Sale+OE | 10,000 | $28.73 | $287,334.39 | -1.8% | |
| Aug 4, 2020 | Stephenson Brian C | See Remarks | Sell | 7,200 | $27.26 | $196,288.64 | -0.6% | |
| Aug 4, 2020 | Kumar Neil | CEO And President | Sell | 80,000 | $27.23 | $2,178,066.07 | -0.9% |